Dr. Hazel Villanueva, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8700 Sudley Rd, Manassas, VA 20110 Phone: 703-369-8000 |
Denyse R Bailey, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9430 Forestwood Ln Ste 100, Manassas, VA 20110 Phone: 703-365-0227 |
Frank James Giancola, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8640 Sudley Rd, Suite 306, Manassas, VA 20110 Phone: 703-330-3939 Fax: 703-331-0959 |
Ingrid Denise Johnson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8640 Sudley Rd, Suite 306, Manassas, VA 20110 Phone: 703-330-3939 Fax: 703-331-0959 |
Atinuke Shoaga, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8700 Sudley Road, Prince William Hospital, Manassas, VA 20110 Phone: 703-369-8337 Fax: 703-369-8868 |
News Archive
Researchers at UCLA say it's not just what you eat that makes those pants tighter - it's also genetics. In a new study, scientists discovered that body-fat responses to a typical fast-food diet are determined in large part by genetic factors, and they have identified several genes they say may control those responses.
The Wall Street Journal: "The White House sent an email to members of Congress and other supporters saying that President Barack Obama wants a public insurance option as part of health-care overhaul. Ms. Sebelius seemed to suggest otherwise on Sunday, saying a public option isn't an 'essential element.'"
Approximately half of Americans living with colorectal cancer will develop liver metastases at some point during the course of their disease. Radiofrequency ablation, a minimally invasive treatment that applies heat directly in the tumor causing cancer cell death with minimal associated injury to the surrounding healthy liver, contributes to prolongation of their life by nearly three years, note researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.
Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.
› Verified 4 days ago